Matteo Morotti

19PUBLICATIONS
106CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunologyHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Mar 18, 2025
Bevacizumab, Atezolizumab, and Acetylsalicylic Acid in Recurrent, Platinum-Resistant Ovarian Cancer: The EORTC 1508-GCG Phase II Study.

Susana Banerjee, Eleonora Ghisoni, Anita Wolfer

|Nov 27, 2024
Δ-Peritoneal Cancer Index (Δ-PCI) to Predict Complete Cytoreduction and Histopathological Response to Neoadjuvant Chemotherapy in Ovarian Cancer.

Giulia Spagnol, Sofia Bigardi, Michela Zorzi

|Jul 13, 2024
The Impact of Neoadjuvant Chemotherapy on Ovarian Cancer Tumor Microenvironment: A Systematic Review of the Literature.

Giulia Spagnol, Eleonora Ghisoni, Matteo Morotti

|Apr 24, 2024
PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function.

Matteo Morotti, Alizee J Grimm, Helen Carrasco Hope

|Apr 24, 2024
PGE2 limits effector expansion of tumour-infiltrating stem-like CD8+ T cells.

Sebastian B Lacher, Janina Dörr, Gustavo P de Almeida

|Feb 02, 2024
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8+ T-myeloid cell networks in melanoma.

David Barras, Eleonora Ghisoni, Johanna Chiffelle

Pageof 4

Frequent Collaborators

6 joint publications

Roberto Tozzi

5 joint publications

Denarda Dangaj Laniti

4 joint publications

Hooman Soleymani Majd

3 joint publications

Jvan Casarin